Csenge Advisory Group Baxter International Inc Transaction History

Csenge Advisory Group

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$49.7 - $57.71 $10,437 - $12,119	210 Added 3.98%	5,486 $279,000
Q3 2022 Oct 04, 2022	SELL	$53.86 - $66.8 $36,732 - $45,557	-682 Reduced 11.45%	5,276 $284,000
Q2 2022 Jul 27, 2022	SELL	$63.83 - $80.0 $10,085 - $12,640	-158 Reduced 2.58%	5,958 $383,000
Q1 2022 May 09, 2022	BUY	$76.85 - $89.45 $76,619 - $89,181	997 Added 19.48%	6,116 $474,000
Q4 2021 Feb 10, 2022	SELL	$74.57 - $87.19 $66,218 - $77,424	-888 Reduced 14.78%	5,119 $417,000
Q3 2021 Oct 20, 2021	BUY	$73.77 - $83.61 $65,507 - $74,245	888 Added 17.35%	6,007 $488,000
Q2 2021 Jul 21, 2021	BUY	$80.5 - $88.01 $2,495 - $2,728	31 Added 0.61%	5,119 $417,000
Q1 2021 Apr 28, 2021	BUY	$76.38 - $86.03 $388,621 - $437,720	5,088 New	5,088 $432,000
Q4 2018 Feb 07, 2019	SELL	$61.45 - $77.8 $8,787 - $11,125	-143 Closed	0 $0
Q3 2018 Nov 19, 2018	BUY	$70.71 - $77.75 $10,111 - $11,118	143 New	143 $9,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

Stay updated on Csenge Advisory Group with notifications on news.